Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
The updated guidance is over 100% higher than previously issued guidance as a result of the Company's expansion in operations following a series of recent transactions. Pro forma 2024 Adjusted EBITDA of $6.0 million - $7.0 million, a 133% increase from the previous 2024 Adjusted EBITDA guidance of $2.5 million - $3.0 million.
Posted In: GNS